#USA #Tempe #GammaTile #GT Medical #Rush University

GT Medical Technologies Expands GammaTile Network

GT Medical Technologies has taken a significant step forward in enhancing brain tumor treatment by designating Rush University Medical Center as the latest GammaTile® Center of Excellence. This prestigious designation recognizes healthcare institutions that demonstrate outstanding clinical proficiency and commitment to patient education in the field of brain tumor therapies.

The Importance of the GammaTile Center of Excellence Designation

The GammaTile program aims to identify and celebrate healthcare providers who excel in patient care. The designation is not just a title; it signifies a rigorous commitment to maintaining high clinical standards and the latest treatment methodologies. Institutions must meet specific criteria, including annual case minimums, clinical benchmarks, and ongoing education for their medical staff to achieve this recognition.

Celebrated Physicians

The team of physicians at Rush University Medical Center who are now recognized for their expertise in the GammaTile procedure includes:

• - Dr. Stephan Munich, Neurosurgeon
• - Dr. Lorenzo F. Muñoz, Neurosurgeon
• - Dr. Ken Tatebe, MD, PhD, Radiation Oncologist

Dr. Tatebe expressed the pride of the institution, stating, “GammaTile has given us a practical new approach to treating brain tumors, expanding the options we can offer our patients.” This innovative solution leads the way for improved patient care and underscores their ongoing commitment to advancing treatment options.

Innovations in Brain Tumor Treatment

GammaTile represents a breakthrough in the management of brain tumors. This innovative form of radiation therapy is unique because it is applied directly at the tumor site during surgical procedures, setting it apart from conventional therapies that often require a waiting period for wound healing. This immediate application allows the treatment to act when cancer cells are most vulnerable to attack, thereby maximizing effectiveness and minimizing the chance of regrowth.

The need to close the gap between surgery and radiation therapy has been a significant concern in oncological practices. Traditional approaches could delay subsequent treatments, potentially allowing cancer cells to recover. GammaTile intervenes in this timeline by providing localized radiation instantly, directly targeting the tumor site.

About GammaTile

GammaTile is an advanced medical device that consists of a bioabsorbable collagen implant embedded with radiation seeds. Upon surgical removal of the tumor, GammaTile is placed within the cavity, delivering an immediate radiation dose at the precise location where residual cancer cells may linger. Since launching in the U.S. market in March 2020, GammaTile has been adopted by over 100 healthcare facilities, reflecting its growing acceptance and the positive impact it has had on treatment protocols.

The unique construction of GammaTile helps protect nearby healthy brain tissue from unnecessary radiation exposure, further enhancing its appeal among medical professionals and patients alike.

GT Medical Technologies: A Commitment to Patients

Founded by a dedicated group of brain tumor specialists, GT Medical Technologies is steadfast in its mission to meet unmet needs in brain tumor treatment through innovative technology. Their initiatives are focused on improving patient outcomes and providing clinicians with advanced tools to tackle challenging cases.

The designation of Rush University Medical Center as a GammaTile Center of Excellence is a testament to the evolution of brain tumor treatment, with a collective effort towards more effective, immediate, and localized care. As treatments continue to advance, GT Medical Technologies remains at the forefront, shaping the future of oncological care and improving the lives of patients battling brain tumors.

For further information, you can visit gammatile.com and follow their updates on social media platforms such as Facebook, Instagram, LinkedIn, and X.